We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DELAYS RELEASE OF CRITICAL PATH PRIORITIES LIST
FDA DELAYS RELEASE OF CRITICAL PATH PRIORITIES LIST
December 10, 2004
The FDA has delayed progress on its much-touted Critical Path Initiative, which aims to expedite the drug development process, as other issues have occupied the agency’s attention, including safety concerns about marketed drugs.